Back

Optimal Duration of Antibiotic Treatment for Group A Streptococcal Pharyngitis in Children: A Systematic Review and Dose-Response Meta-Analysis

Lima, J. P.; Dorri, M.; Ling, M.; Lee, B.; Kirsh, S.; Dhanoya, S.; Walch, A.; Jassal, T.; Raji Lahiji, M.; Chou, A.; Li, H.; Cui, A.; Chang, O.; Bigler, M.; Pernica, J. M.; Eltorki, M.; Yamamura, D.; Langford, B. J.; Loeb, M.; Tse-Chang, A.; Le Saux, N.; Zeraatkar, D.

2026-07-06 infectious diseases
10.64898/2026.06.25.26356472 medRxiv
Show abstract

Background: Group A streptococcal (GAS) pharyngitis drives substantial antibiotic prescribing in children. The 10-day standard burdens adherence and prolongs exposure, increasing selective pressure for resistance. Yet, whether shorter courses achieve comparable outcomes remains unresolved. Purpose: To address how the duration of oral antibiotics affects clinical outcomes in children and adolescents with suspected or confirmed GAS pharyngitis. Data Sources: MEDLINE, Embase, CENTRAL, Web of Science, and CINAHL from inception to July 2025. Reviewers also searched reference lists of eligible trials and relevant systematic reviews. Study Selection: Randomized trials enrolling children and adolescents [≤]18 years with suspected or confirmed GAS pharyngitis comparing different durations of oral antibiotics, or oral antibiotics against placebo or no treatment. Data Extraction: Paired reviewers independently screened records, extracted data, and assessed risk of bias. Data Synthesis: We performed random-effects dose-response meta-analyses with restricted cubic splines and rated the certainty of evidence using GRADE. Forty-five trials enrolling 22,636 participants met eligibility criteria. Across outcomes, low to moderate certainty evidence suggests that 3, 5, and 10 days of antibiotic treatment may produce little to no difference. Moderate certainty evidence supports similar effects of 5 and 10 days on clinical cure, relapse, and adverse events. Evidence comparing 3 and 10 days carries lower certainty. Serious adverse events were rare: no deaths, 4 cases of acute rheumatic fever, and 4 cases of post-streptococcal glomerulonephritis among 776, 8,818, and 9,096 participants, respectively, making clinically important differences across treatment durations unlikely. Limitations: Evidence on 3-day courses came almost exclusively from trials of azithromycin, limiting inference about shorter penicillin regimens. Findings apply most directly to high-income settings. Conclusion: These findings challenge the long-standing 10-day standard for pediatric GAS pharyngitis and show that 5 days of oral antibiotics are likely as effective and safe as 10 days.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
BMC Infectious Diseases
133 papers in training set
Top 0.1%
8.1%
2
PLOS ONE
5266 papers in training set
Top 21%
8.1%
3
The Journal of Infectious Diseases
202 papers in training set
Top 0.2%
8.1%
4
Clinical Infectious Diseases
235 papers in training set
Top 0.3%
6.9%
5
BMJ Open
601 papers in training set
Top 6%
3.3%
6
Journal of Antimicrobial Chemotherapy
46 papers in training set
Top 0.3%
3.3%
7
Vaccine
203 papers in training set
Top 0.9%
2.9%
8
PLOS Neglected Tropical Diseases
466 papers in training set
Top 3%
2.4%
9
Nature Communications
5641 papers in training set
Top 39%
2.4%
10
eLife
5828 papers in training set
Top 43%
2.2%
11
PLOS Global Public Health
344 papers in training set
Top 5%
2.2%
12
Pediatric Infectious Disease Journal
17 papers in training set
Top 0.1%
2.2%
50% of probability mass above
13
The Lancet Rheumatology
11 papers in training set
Top 0.1%
2.2%
14
BMJ
51 papers in training set
Top 0.5%
1.8%
15
Open Forum Infectious Diseases
142 papers in training set
Top 2%
1.8%
16
BMC Medicine
176 papers in training set
Top 3%
1.5%
17
Clinical Microbiology and Infection
62 papers in training set
Top 0.4%
1.5%
18
Frontiers in Immunology
638 papers in training set
Top 6%
1.5%
19
Wellcome Open Research
67 papers in training set
Top 0.8%
1.5%
20
PLOS Medicine
110 papers in training set
Top 2%
1.4%
21
The Lancet Microbe
44 papers in training set
Top 0.6%
1.2%
22
Infectious Diseases and Therapy
18 papers in training set
Top 0.2%
1.2%
23
European Respiratory Journal
59 papers in training set
Top 0.8%
1.2%
24
JCI Insight
277 papers in training set
Top 5%
1.2%
25
International Journal of Antimicrobial Agents
15 papers in training set
Top 0.3%
1.1%
26
The Lancet
16 papers in training set
Top 0.2%
1.1%
27
Annals of the Rheumatic Diseases
36 papers in training set
Top 0.4%
1.0%
28
Journal of the Pediatric Infectious Diseases Society
10 papers in training set
Top 0.1%
0.9%
29
Infection
15 papers in training set
Top 0.2%
0.9%
30
Scientific Reports
3612 papers in training set
Top 73%
0.9%